Navigation Links
Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
Date:12/2/2009

NEW YORK, Dec. 2 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Discovery Technologies - A Global Update of Market Trends & Opportunities

http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html

Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D. These technologies include bioanalytical instruments, genomics, pharmacogenomics, combinatorial chemistry, biochip, proteomics, bioinformatics and high throughput screening (HTS). Use of emerging technologies in drug discovery such as lab on a chip (LOC), nanotechnology and RNA interference (RNAi) is increasing at a rapid pace given their ability to expedite, and improve the efficiency of drug discovery processes and reducing time-to-market.

These and other market data and trends are presented in "Drug Discovery Technologies: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

DRUG DISCOVERY TECHNOLOGIES BMR-1046

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4

Drug Discovery Outsourcing - A Necessity 4

3. AN OVERVIEW OF KEY EMERGING TECHNOLOGIES 5

Bioinformatics 5

Pharmacogenomics 5

Theragnostics 7

Targeted Therapy 8

Mass Spectrometry - A New Catalyst for Technological Developments 8

Tandem LC/MS Market 9

FT-MS Market 9

MALDI-TOF Market 10

GC/MS Market 10

Magnetic MS Market 10

4. MARKET TRENDS 10

New Technologies Fire Up Drug Discovery Market 10

Obesity Related Diseases Driving Drug Discovery Research 11

Biochips Change Face of Drug Discovery 11

Genomics and Proteomics Gaining Prominence 11

Genomics Drives Bioinformatics Growth in Drug Discovery 12

Market Scenario of Human Genome Sciences (HGS) 12

International Initiatives Expand Proteomics 13

5. PRODUCT FACTS 13

Bioanalytical Instruments 13

Nuclear Magnetic Resonance 13

Mass Spectroscopy 14

Microplate Readers 14

Chemotherapy Instruments 14

High Throughput Screening (HTS) 14

Genomics 14

Proteomics 14

Bioinformatics 14

Biochip 15 Pharmacogenomics 15

Other Drug Discovery Technologies 15

6. CORPORATE DEVELOPMENTS 15

Affymetrix Acquires USB Corp 15

Roche Acquires Ventana Medical Systems 15

Bruker BioSciences Acquires Bruker BioSpin Group 16

Takeda Signs Agreement to Take Over Millennium 16

Implant Sciences to Acquire Ion Metrics 17

NascaCell and Archemix Expand Partnership for Aptamer-Based Drugs 17

DiscoveRx and Cosmo Bio Sign Distribution Agreement 18

Zydus Cadila Enters into Collaboration with Prolong

Pharmaceuticals 18

PsychoGenics Enters into Drug Discovery Agreement with Dainippon 19

Zydus Cadila Collaborates with Karo Bio 19

Dr. Reddy's Signs Collaboration Agreement with 7TM Pharma 20

Synamatix Enters into Collaboration with Universiti Malaysia 21

Monogram Enters into Exclusive Collaboration Agreement with Avexa 21

Caliper Life Sciences Collaborates with Horizon Discovery 22

Galapagos Signs Collaborative Agreement with Allergan for Drug

Discovery 22

Sigma-Aldrich Inks Exclusive Distribution Partnership with

Atlas Antibodies 23

PsychoGenics Enters into New Agreement with Eli Lilly 23

BioFocus DPI Extends Contract with Lilly 24

Invitrogen to Collaborate with Tecan 24

Ranbaxy Forms New Drug Discovery Company 25

Affymetrix Introduces Cytogenetic Solution 25

Affymetrix Introduces DMET Early Access Solution 26

Affymetrix Microarray Platform to feature in Pathwork's

Diagnostic Test 26

Bio-Rad Laboratories Rolls Out Vasculitis Kit for BioPlex 2200

System 26

PerkinElmer Develops Products for High-Throughput Screening 27

Tecan to Introduce Multimode Microplate Reader- Infinite M1000 27

Tripos International Launches SYBYL®8.0 27

Eli Lilly Acquires ICOS Corporation 28

CMC Announces Acquisition of ICOS Biologics Facility from Eli

Lilly 28

SurModics Acquires Brookwood 28

Commonwealth Biotechnologies Acquires Tripos Discovery Research 29

VASTox Acquires Dextra Laboratories and Daniolabs 29

Wyeth Completes the Acquisition of Haptogen 31

Roche Takes Over Nimblegen 31

AMRI Acquires Pharmaceutical Manufacturing Units in India 32

Agilent Technologies Acquires Stratagene 32

AstraZeneca Takes Over MedImmune 33

Ocimum Acquires Gene Logic's Genomics Business 33

Newsham Genetics Acquires Monsanto Choice Genetics 34

Evotec Takes Over Combinature Biopharm's Drug Discovery Unit 34

BioServe Takes Over Genomics Collaborative 34

Thomson Takes Over Unleashed Informatics Ltd 35

Thomson Completes Acquisition of Prous Science 35

MDS Acquires Molecular Devices 36

Evotec to Take over Renovis 36

Ecopia Merges with Caprion 37

Thallion Sells Majority Interest in Caprion Proteomics Business 37

Affymetrix Enters into Licensing Agreement with Empire Genomics 37

Graffinity Pharmaceuticals Signs Drug Discovery Agreement with

Amgen 38

ArQule Signs License Deal with Kyowa Hakko 38

Orion and ChemDiv Enter into Collaborative Deal 39

Graffinity Enters into Drug Discovery Collaboration with Pfizer 39

Tata Enterprise Establishes Pharmaceutical Development Centre 40

Nicholas Piramal Collaborates with Merck 40

Eksigent Signs Distribution Agreement with Interface Engineering 40

MDS Pharma Expands Chinese Lab Operations 41

Abbott and Caprion Proteomics Extends Partnership 41

Agilent Technologies and BioNanomatrix Enters into Collaboration 42

Evotec Extends Partnership with Boehringer Ingelheim 43

Evotec and Interprotein Enter into Collaboration 43

Galapagos Forms Drug Innovation Alliance with AstraZeneca 43

Proteome Systems and BD Enter into an Agreement 44

Galapagos Extends Drug Innovation Partnership with Amgen 44

Dimerix Collaborates with NCDS 45

ACE BioSciences and CLC Bio Enter into Collaborative Agreement 46

Ambrx Enters into Strategic Agreement with Merck & Co 46

Galapagos and Cystic Fibrosis Collaborate for Drug Discovery 47

BioDiscovery Collaborates with Illumina 47

Jubilant & Forest Enter into Partnership Deal 48

Invitrogen Corporation Signs Agreement with Emiliem to Screen

Kinase Inhibitors 48

AMRI Establishes New Center in India 49

Bio-Rad Laboratories Unveils In2it A1C Analyzer for Diabetic

Patients 49

Charles River Launches Endosafe®-MCS(TM) Endotoxin Detection System 49

Invitrogen Launches Human Embryonic Stem Cells Monitoring Kit 50

Sigma-Aldrich Introduces Proteomics Dynamic Range Standard 50

Molecular Devices Develops Arcturus (XT)(TM) LMC Instrument 50

Fujitsu's BioSciences Renames CAChe Software and Releases

Scigress Explorer(TM) 51

Tripos International Unveils Topomer CoMFA® 51

Tripos International Launches Topomer Search 51

7. MAJOR PLAYERS 52

Abbott Laboratories (US) 52

Affymetrix Inc. (US) 52

Agilent Technologies Inc. (US) 52

Albany Molecular Research, Inc. (US) 52

Amersham Biosciences (US) 52

Applera Corporation (US) 53

ArQule Inc. (US) 53

AstraZeneca (UK) 53

BD Biosciences (US) 53

Bio-Rad Laboratories, Inc. (US) 54

BioSciences Group (Japan) 54

Caliper Life Sciences, Inc. (US) 54

Capital GenomiX (US) 54

Caprion Proteomics (Canada) 55

Charles River Laboratories International, Inc. (US) 55

ChemBridge Corporation (US) 55

deCODE Genetics, Inc (Iceland) 55

Evotec AG (Germany) 55

Galapagos NV (Belgium) 55

Incyte Corporation (Formerly Incyte Genomics Inc.) (US) 56

Infinity Pharmaceuticals, Inc. (US) 56

Invitrogen Corporation (US) 56

Medarex, Inc. (US) 56

Merck & Co., Inc. (US) 56

Millennium Pharmaceuticals, Inc. (US) 56

National Center for Drug Screening (China) 57

PerkinElmer, Inc. (US) 57

Pharmacopeia Inc. (US) 57

Proteome Systems (Australia) 57

Quantum Pharmaceuticals (Russia) 57

Shimadzu Corporation (Japan) 58

Sigma-Aldrich (US) 58

Tecan Group (Switzerland) 58

Thallion Pharmaceuticals, Inc. (Canada) 58

Tripos International (US) 58

8. MARKET ANALYTICS 59

9. THE UNITED STATES 68

Overview 68

US Leads the World High Throughput Screening (HTS) Market 68

10. CANADA 70

11. JAPAN 71

Japan Resembles US in Life Science Research 71

12. EUROPE 73

An Overview of Pharmacogenomics and Personalized Medicine 73

Emerging Trends in Proteomics Technology 74

Protein Classification 75

Protein Separation 76

Market Trends 77

European Market for Drug Discovery Tools 77

UK Government Supports Proteomics Research 77

Drug Discovery Outsourcing in Europe 77

13. REST OF WORLD 79

Asia-Pacific 79

Emerging Opportunities 79

Cost Advantage in Asia Attracts Global Drug Discovery Industry 79

Regulations Affect Asia-Pacific Drug Discovery Market 79

India 79

Bioinformatics Market in India 79

Scope and Demand for Bioinformatics Market to Expand

Significantly by 2010 80

Discovery of Therapeutic Molecules - A New Buzzword for

Growth Acceleration 81

EXHIBITS

Table 1: Global Drug Discovery Technologies Market by Region

for the Period 2007-2015 (Sales in US$ Million)

Table 2: Percentage Breakdown of Global Drug Discovery

Technologies Market by Region for the Years 2008 & 2012

Table 3: Global Bioanalytical Instruments Market by Region for

the Period 2007-2015 (Sales in US$ Million)

Table 4: Percentage Breakdown of Global Bioanalytical

Instruments Market by Region for the Years 2008 & 2012

Table 5: Global High Throughput Screening (HTS) Market by

Region for the Period 2007-2015 (Sales in US$ Million)

Table 6: Percentage Breakdown of Global High Throughput

Screening (HTS) Market by Region for the Years 2008 & 2012

Table 7: Global Biochip Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 8: Percentage Breakdown of Global Biochip Market by

Region for the Years 2008 & 2012

Table 9: Global Proteomics Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 10: Percentage Breakdown of Global Proteomics Market by

Region for the Years 2008 & 2012

Table 11: Global Genomics Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 12: Percentage Breakdown of Global Genomics Market by

Region for the Years 2008 & 2012

Table 13: Global Bioinformatics Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 14: Percentage Breakdown of Global Bioinformatics Market

by Region for the Years 2008 & 2012

Table 15: Global Pharmacogenomics Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 16: Percentage Breakdown of Global Pharmacogenomics

Market by Region for the Years 2008 & 2012

Table 17: Global Other Drug Discovery Technologies Market by

Region for the Period 2007-2015 (Sales in US$ Million)

Table 18: Percentage Breakdown of Global Other Drug Discovery

Technologies Market by Region for the Years 2008 & 2012

Table 19: The US Market for Drug Discovery Technologies Market

by Type: 2007-2015 (Sales in US$ Million)

Table 20: Percentage Breakdown of the US Market for Drug

Discovery Technologies Market by Type for the Years 2008 &

2012

Table 21: The Canadian Market for Drug Discovery Technologies

Market by Type: 2007-2015 (Sales in US$ Million)

Table 22: Percentage Breakdown of the Canadian Market for Drug

Discovery Technologies Market by Type for the Years 2008 &

2012

Table 23: The Japanese Market for Drug Discovery Technologies

Market by Type: 2007-2015 (Sales in US$ Million)

Table 24: Percentage Breakdown of the Japanese Market for Drug

Discovery Technologies Market by Type for the Years 2008 &

2012

Table 25: The European Market for Drug Discovery Technologies

Market by Type: 2007-2015 (Sales in US$ Million)

Table 26: Percentage Breakdown of the European Market for Drug

Discovery Technologies Market by Type for the Years 2008 &

2012

Table 27: The Rest of World Market for Drug Discovery

Technologies Market by Type: 2007-2015 (Sales in US$ Million)

Table 28: Percentage Breakdown of Rest of World Market for

Drug Discovery Technologies Market by Type for the Years 2008

& 2012

COMPANIES PROFILED

To order this report:

Medical Equipment and Supply Industry: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
2. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Reportlinker Adds Nanomedicine Report
5. Reportlinker Adds Small Molecule Kinase Inhibitors Report
6. Reportlinker Adds Nanoporous Materials Report
7. Reportlinker Adds Membrane Bioreactors Report
8. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
9. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Reportlinker Adds Stem Cell Therapeutics Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... announced that it has joined the Human Vaccines Project, a public-private partnership ... and cancer. , The Human Vaccines Project brings together leading pharmaceutical ...
(Date:2/10/2016)... ... February 10, 2016 , ... HOLLOWAY AMERICA, ... Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition on Thursday, February ... than 100 tables for its annual event, which will run from 3:00 p.m. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Global Stem ... agreement with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global ... in the latest adipose and bone marrow therapies. , Through the new ...
Breaking Biology Technology:
(Date:2/9/2016)... Mass., Feb. 9, 2016 Aware, Inc. (NASDAQ: AWRE ... financial results for its fourth quarter and year ended December 31, ... for the fourth quarter of 2015 was $6.9 million, an increase ... year. Operating income in the fourth quarter of 2015 was $2.6 ... --> --> Higher revenue ...
(Date:2/3/2016)... GOTHENBURG, Sweden , February 4, 2016 ... Revenues amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth ... Operating profit amounted to SEK 517.6 M (loss: 30.0). Earnings ... from operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% ...
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
Breaking Biology News(10 mins):